Cachectic muscle wasting in acute myeloid leukaemia: a sleeping giant with dire clinical consequences

Campelj, Dean G, Timpani, Cara ORCID: 0000-0003-4567-4319 and Rybalka, Emma ORCID: 0000-0002-4854-0036 (2022) Cachectic muscle wasting in acute myeloid leukaemia: a sleeping giant with dire clinical consequences. Journal of Cachexia, Sarcopenia and Muscle, 13 (1). pp. 42-54. ISSN 2190-5991

Abstract

Acute myeloid leukaemia (AML) is a haematological malignancy with poor survival odds, particularly in the older (>65 years) population, in whom it is most prevalent. Treatment consists of induction and consolidation chemotherapy to remit the cancer followed by potentially curative haematopoietic cell transplantation. These intense treatments are debilitating and increase the risk of mortality. Patient stratification is used to mitigate this risk and considers a variety of factors, including body mass, to determine whether a patient is suitable for any or all treatment options. Skeletal muscle mass, the primary constituent of the body lean mass, may be a better predictor of patient suitability for, and outcomes of, AML treatment. Yet skeletal muscle is compromised by a variety of factors associated with AML and its clinical treatment consistent with cachexia, a life-threatening body wasting syndrome. Cachectic muscle wasting is associated with both cancer and anticancer chemotherapy. Although not traditionally associated with haematological cancers, cachexia is observed in AML and can have dire consequences. In this review, we discuss the importance of addressing skeletal muscle mass and cachexia within the AML clinical landscape in view of improving survivability of this disease.

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/43339
DOI https://doi.org/10.1002/jcsm.12880
Official URL https://onlinelibrary.wiley.com/doi/10.1002/jcsm.1...
Subjects Current > FOR (2020) Classification > 3202 Clinical sciences
Current > Division/Research > Institute for Health and Sport
Keywords acute myeloid leukaemia, AML, chemotherapy, complete remission, CR, hematopoietic cell transplantation, HCT, cachexia, sarcopenia
Citations in Scopus 0 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login